295 related articles for article (PubMed ID: 34729701)
1. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
[TBL] [Abstract][Full Text] [Related]
2. Enhanced dissolution and stability of adefovir dipivoxil by cocrystal formation.
Gao Y; Zu H; Zhang J
J Pharm Pharmacol; 2011 Apr; 63(4):483-90. PubMed ID: 21401599
[TBL] [Abstract][Full Text] [Related]
3. Coformer selection based on degradation pathway of drugs: a case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-nicotinamide cocrystals.
Gao Y; Gao J; Liu Z; Kan H; Zu H; Sun W; Zhang J; Qian S
Int J Pharm; 2012 Nov; 438(1-2):327-35. PubMed ID: 22989978
[TBL] [Abstract][Full Text] [Related]
4. Thermodynamic and kinetic investigation on the crucial factors affecting adefovir dipivoxil-saccharin cocrystallization.
Ma K; Zhang Y; Kan H; Cheng L; Luo L; Su Q; Gao J; Gao Y; Zhang J
Pharm Res; 2014 Jul; 31(7):1766-78. PubMed ID: 24522813
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel adefovir dipivoxil-saccharin cocrystal polymorphs and their thermodynamic polymorphic transformations.
Ma K; Wang N; Cheng L; Wei Y; Zhang J; Gao Y; Qian S
Int J Pharm; 2019 Jul; 566():361-370. PubMed ID: 31152792
[TBL] [Abstract][Full Text] [Related]
7. In Vitro-In Vivo Correlation in Cocrystal Dissolution: Consideration of Drug Release Profiles Based on Coformer Dissolution and Absorption Behavior.
Kataoka M; Minami K; Takagi T; Amidon GE; Yamashita S
Mol Pharm; 2021 Nov; 18(11):4122-4130. PubMed ID: 34618448
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical Cocrystal: A Novel Approach to Tailor the Biopharmaceutical Properties of a Poorly Water Soluble Drug.
Srivastava D; Fatima Z; Kaur CD; Tulsankar SL; Nashik SS; Rizvi DA
Recent Pat Drug Deliv Formul; 2019; 13(1):62-69. PubMed ID: 30848223
[TBL] [Abstract][Full Text] [Related]
9. The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals.
Ren S; Liu M; Hong C; Li G; Sun J; Wang J; Zhang L; Xie Y
Acta Pharm Sin B; 2019 Jan; 9(1):59-73. PubMed ID: 30766778
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
Basavoju S; Boström D; Velaga SP
Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of adefovir dipivoxil-stearic acid cocrystal with enhanced physicochemical properties.
Seo JW; Hwang KM; Lee SH; Kim DW; Park ES
Pharm Dev Technol; 2018 Nov; 23(9):890-899. PubMed ID: 28535125
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of physicochemical, pharmaceutical, and pharmacokinetic properties of lornoxicam by cocrystallization with a novel coformer.
Fatima K; Bukhari NI; Latif S; Afzal H; Hussain A; Shamim R; Abbas N
Drug Dev Ind Pharm; 2021 Mar; 47(3):498-508. PubMed ID: 33646919
[TBL] [Abstract][Full Text] [Related]
13. Mechanism study on stability enhancement of adefovir dipivoxil by cocrystallization: Degradation kinetics and structure-stability correlation.
Lin RZ; Sun PJ; Tao Q; Yao J; Chen JM; Lu TB
Eur J Pharm Sci; 2016 Mar; 85():141-8. PubMed ID: 26462447
[TBL] [Abstract][Full Text] [Related]
14. Effects of Coformer and Polymer on Particle Surface Solution-Mediated Phase Transformation of Cocrystals in Aqueous Media.
Omori M; Watanabe T; Uekusa T; Oki J; Inoue D; Sugano K
Mol Pharm; 2020 Oct; 17(10):3825-3836. PubMed ID: 32870691
[TBL] [Abstract][Full Text] [Related]
15. Cocrystals of Hydrochlorothiazide: Solubility and Diffusion/Permeability Enhancements through Drug-Coformer Interactions.
Sanphui P; Devi VK; Clara D; Malviya N; Ganguly S; Desiraju GR
Mol Pharm; 2015 May; 12(5):1615-22. PubMed ID: 25800383
[TBL] [Abstract][Full Text] [Related]
16. Effects of 1α,25-Dihydroxyvitamin D3 on Intestinal Absorption and Disposition of Adefovir Dipivoxil and Its Metabolite, Adefovir, in Rats.
Yoon IS; Son JH; Kim SB; Choi MK; Maeng HJ
Biol Pharm Bull; 2015; 38(11):1732-7. PubMed ID: 26521823
[TBL] [Abstract][Full Text] [Related]
17. Small-Scale Assays for Studying Dissolution of Pharmaceutical Cocrystals for Oral Administration.
Box KJ; Comer J; Taylor R; Karki S; Ruiz R; Price R; Fotaki N
AAPS PharmSciTech; 2016 Apr; 17(2):245-51. PubMed ID: 26208438
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of electrospray deposition for rapid screening of the cocrystal formation and single step, continuous production of pharmaceutical nanococrystals.
Emami S; Siahi-Shadbad M; Barzegar-Jalali M; Adibkia K
Drug Dev Ind Pharm; 2018 Jun; 44(6):1034-1047. PubMed ID: 29347850
[TBL] [Abstract][Full Text] [Related]
19. Baicalein-nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability.
Huang Y; Zhang B; Gao Y; Zhang J; Shi L
J Pharm Sci; 2014 Aug; 103(8):2330-7. PubMed ID: 24903146
[TBL] [Abstract][Full Text] [Related]
20. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.
Cundy KC; Sue IL; Visor GC; Marshburn J; Nakamura C; Lee WA; Shaw JP
J Pharm Sci; 1997 Dec; 86(12):1334-8. PubMed ID: 9423141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
